24
Participants
Start Date
March 5, 2018
Primary Completion Date
March 11, 2024
Study Completion Date
March 11, 2024
Denosumab
Each subcutaneous injection will occur every 6 months during 3 years for a total of 7 injections
Placebo
Each subcutaneous injection will occur every 6 months during 3 years for a total of 7 injections
La Timone Hospital, Dermatology and cutaneous oncology department, Marseille
Caen Hospital, Clinical haematology department, Caen
Jean Minjoz Hospital, Dermatology department, Besançon
Toulouse Hospital, Dermatology department, Toulouse
Lapeyronie Hospital, Rheumatology and Immunology department, Montpellier
Lille CHRU Hospital, Internal medicine and clinical immunology department, Lille
Estaing Hospital, Cellular therapy and clinical haematology department, Clermont-Ferrand
Strasbourg Hospital, Rheumatology department, Strasbourg
La Pitié-Salpêtrière Hospital, Internal medicine and clinical immunology department, Paris
Cochin Hospital, Rheumatology department, Paris
Necker Hospital, Adult haematology department, Paris
CEREMAST
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER